6 results
40-F
2021 FY
EX-99.1
THTX
Theratechnologies Inc.
24 Feb 22
Annual report (Canada)
8:02am
with applicable GCPs or other applicable requirements, such as informed consent or Institutional Review Board oversight, the clinical data generated
40-F
2020 FY
EX-99.1
THTX
Theratechnologies Inc.
25 Feb 21
Annual report (Canada)
8:31am
with applicable GCPs or other applicable requirements, such as informed consent or Institutional Review Board oversight, the clinical data generated
40-F
2019 FY
EX-99.1
THTX
Theratechnologies Inc.
25 Feb 20
Annual report (Canada)
8:11am
GCPs or other applicable requirements, such as informed consent or Institutional Review Board oversight, the clinical data generated in clinical
40FR12B
EX-99.1
THTX
Theratechnologies Inc.
27 Sep 19
Initial registration of securities (Canada)
5:05pm
Board oversight, the clinical data generated in our clinical trials may be deemed unreliable and the FDA may require us to redo our studies or stop
40FR12B
EX-99.38
7ed2iq2d2yy6b11r
27 Sep 19
Initial registration of securities (Canada)
5:05pm
- Prev
- 1
- Next